Thierry Ory

Thierry Ory

UNVERIFIED PROFILE

Are you Thierry Ory?   Register this Author

Register author
Thierry Ory

Thierry Ory

Publications by authors named "Thierry Ory"

Are you Thierry Ory?   Register this Author

3Publications

80Reads

43Profile Views

Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells.

Oncogene 2005 Sep;24(41):6213-21

Department of Discovery Medicine, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina, NC 27709-3398, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208774DOI Listing
September 2005